Fabrazyme 35 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDL31
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,829
Award facts
- Contract value 100% obligated
- $33,828.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $33.8K by the Defense Logistics Agency (DLA) for the supply of Fabrazyme 35 mg vials. This firm fixed-price delivery order, issued on August 21, 2025, carries an ultimate completion date of September 12, 2025, with performance taking place at the contractor's Park Ridge facility. The award does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis in the federal procurement marketplace.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion through the SPE2DB program, which expires in November 2026. The IDC establishes a comprehensive pharmaceutical supply arrangement supporting Department of Defense healthcare facilities worldwide, enabling the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables across multiple product categories. As a key supplier within the federal pharmaceutical supply chain since its SAM.gov registration in 2001, DMS Pharmaceutical Group maintains a robust portfolio of contract awards with DLA for specialized pharmaceutical products serving military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FDL31?
SPE2DB25FDL31 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FDL31 worth?
The government has obligated $33,829 on SPE2DB25FDL31.
Is contract SPE2DB25FDL31 an order under another contract?
Yes. SPE2DB25FDL31 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL31 competed?
The extent of competition for SPE2DB25FDL31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award